These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30615804)

  • 41. Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodies.
    Brenneis C; Wenning GK; Egger KE; Schocke M; Trieb T; Seppi K; Marksteiner J; Ransmayr G; Benke T; Poewe W
    Neuroreport; 2004 Aug; 15(11):1711-4. PubMed ID: 15257132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.
    Villemagne VL; Okamura N; Pejoska S; Drago J; Mulligan RS; Chételat G; Ackermann U; O'Keefe G; Jones G; Gong S; Tochon-Danguy H; Kung HF; Masters CL; Skovronsky DM; Rowe CC
    Arch Neurol; 2011 Jul; 68(7):905-12. PubMed ID: 21747030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional connectivity in cortical regions in dementia with Lewy bodies and Alzheimer's disease.
    Kenny ER; Blamire AM; Firbank MJ; O'Brien JT
    Brain; 2012 Feb; 135(Pt 2):569-81. PubMed ID: 22189566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.
    Massa F; Arnaldi D; De Cesari F; Girtler N; Brugnolo A; Grazzini M; Bauckneht M; Meli R; Morbelli S; Pardini M; Sambuceti G; De Carli F; Tiraboschi P; Nobili F
    Neurobiol Aging; 2019 Apr; 76():9-17. PubMed ID: 30611093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies.
    Lee YG; Jeon S; Yoo HS; Chung SJ; Lee SK; Lee PH; Sohn YH; Yun M; Evans AC; Ye BS
    Neurobiol Aging; 2018 Dec; 72():32-39. PubMed ID: 30205358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    Gupta HV; Beach TG; Mehta SH; Shill HA; Driver-Dunckley E; Sabbagh MN; Belden CM; Liebsack C; Dugger BN; Serrano GE; Sue LI; Siderowf A; Pontecorvo MJ; Mintun MA; Joshi AD; Adler CH
    J Alzheimers Dis; 2021; 80(4):1603-1612. PubMed ID: 33720879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of microglial activation with white matter changes in dementia with Lewy bodies.
    Nicastro N; Mak E; Williams GB; Surendranathan A; Bevan-Jones WR; Passamonti L; Vàzquez Rodrìguez P; Su L; Arnold R; Fryer TD; Hong YT; Aigbirhio FI; Rowe JB; O'Brien JT
    Neuroimage Clin; 2020; 25():102200. PubMed ID: 32032816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
    Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
    Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies.
    Ferreira D; Przybelski SA; Lesnick TG; Schwarz CG; Diaz-Galvan P; Graff-Radford J; Senjem ML; Fields JA; Knopman DS; Jones DT; Savica R; Ferman TJ; Graff-Radford N; Lowe VJ; Jack CR; Petersen RC; Westman E; Boeve BF; Kantarci K
    Neurology; 2023 Feb; 100(8):e846-e859. PubMed ID: 36443011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases.
    Brumberg J; Blazhenets G; Bühler S; Fostitsch J; Rijntjes M; Ma Y; Eidelberg D; Weiller C; Jost WH; Frings L; Schröter N; Meyer PT
    Ann Neurol; 2024 Sep; 96(3):539-550. PubMed ID: 38888141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dementia with Lewy bodies studied with positron emission tomography.
    Cordery RJ; Tyrrell PJ; Lantos PL; Rossor MN
    Arch Neurol; 2001 Mar; 58(3):505-8. PubMed ID: 11255457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging.
    Villemagne VL; Okamura N; Pejoska S; Drago J; Mulligan RS; Chételat G; O'Keefe G; Jones G; Kung HF; Pontecorvo M; Masters CL; Skovronsky DM; Rowe CC
    Neurodegener Dis; 2012; 10(1-4):161-5. PubMed ID: 22261520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
    Yong SW; Yoon JK; An YS; Lee PH
    Eur J Neurol; 2007 Dec; 14(12):1357-62. PubMed ID: 17941855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
    Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
    Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD
    Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "Occipital Tunnel" Sign on FDG PET for Differentiating Dementias.
    Sawyer DM; Kuo PH
    Clin Nucl Med; 2018 Feb; 43(2):e59-e61. PubMed ID: 29232244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.